3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow LPCN 1021: new trials by email Literature Review of LPCN 1021 trials Research Report on LPCN 1021
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men LPCN 1021 - Hypogonadism, Male | Phase 3 | Completed | Lipocine Inc. | 138 | 2018-04-30 | 2021-06-10 |
| Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021) LPCN 1021 - Hypogonadism, Male | Phase 3 | Completed | Lipocine Inc. | 100 | 2017-01-01 | 2019-10-23 |
| Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021). LPCN 1021 - Hypogonadism, Male | Phase 3 | Completed | Lipocine Inc. | 95 | 2016-12-01 | 2019-10-23 |
Eunuchism (3)
Lipocine Inc. (3)
United States (1)
Anthony DelConte, MD (2) · Anthony Delconte, MD (1)